COMP <GO>
MLAB vs ENVX // PIOTROSKI F-SCORE QUALITY
Mesa Laboratories Inc. (NASDAQ) VS. Enovix Corporation (NASDAQ) • 15-METRIC TALLY: MLAB 8
— ENVX 3
▲ PIOTROSKI F-SCORE QUALITY LEADER: MLAB
LAST: $133.03 (+1.30%) • MKT CAP: $744.4M
piotroski-score
7/9
LAST: $3.51 (-0.28%) • MKT CAP: $770.3M
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MLAB VS. ENVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MLAB | ENVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 63.50% | 19.20% | +44.30 | MLAB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.30% | -20.50% | +29.80 | MLAB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 33.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.32% | -14.74% | +20.06 | MLAB | /fcf-yield <GO> |
| Operating Margin | 7.40% | -60.00% | +67.40 | MLAB | /operating-margins <GO> |
| Net Profit Margin | 2.70% | -60.00% | +62.70 | MLAB | /net-margins <GO> |
| Revenue Growth (YoY) | 3.40% | 37.90% | -34.50 | ENVX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.47% | 0.00% | +0.47 | MLAB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.07 | 0.20 | +1.87 | MLAB | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 4/9 | +3.00 | MLAB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.0 | 55.8 | -6.83 | ENVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 103.1x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $744.4M | $770.3M | -$25.8M | ENVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MLAB REV | ENVX REV | MLAB GROSS % | ENVX GROSS % | MLAB FCF | ENVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $249.1M | $31.8M | 63.5% | 19.2% | $39.6M | -$113.5M |
| FY 2024 | $241.0M | $23.1M | 62.6% | -8.9% | $42.6M | -$184.8M |
| FY 2023 | $216.2M | $7.6M | — | — | $44.1M | -$104.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MLAB // BETA —
ENVX // BETA —